For Patients, Not Profits
A new not-for-profit company will manufacture important generics in the US
Back in January 2018, “Project Rx” was announced – an ambitious initiative to establish a not-for-profit generic drug company. Further exciting details have now emerged (1). The company will be called Civica Rx and will be headed by Martin Van Trieste, former chief quality officer at Amgen and number 2 on The Medicine Maker’s Power List of Industry Influencers (2). More than 120 health organizations – representing a third of national hospitals in the US – have expressed an interest in some sort of participation.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.